Precipio Revises Warrant Agreement With Largest Holder; 100K To Be Exercised For Cash, 200K Through Cashless Conversion

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised structure whereby 100,000 warrants (approximately ⅓) shall be exercised with cash, and the remainder (approximately 200,000 warrants) to be exercised in a cashless manner.

The transaction accomplishes two things:

1. Reducing the number of shares that will be added to the Company's outstanding shares from ~300,000 to between ~130,000-150,000 (subject to the share price upon warrant exercise).
2. Receiving ~$1.2M in cash inflow.

This amendment reduces the cash proceeds received to ~$1.2M from ~$3.8M that would have otherwise been received under normal warrant exercise.